Ocaratuzumab Antibody
Ocaratuzumab (AME-133v) is a humanized, Fc-engineered monoclonal antibody that binds CD20 with high affinity (Kd≈100 pM) . It is designed to enhance antibody-dependent cellular cytotoxicity (ADCC), making it a research tool for investigating targeted therapies in chronic lymphocytic leukemia and related B-cell malignancies.
Product Specifications
Product Name Alternative
AME 133v, AME133v, Humanized Anti-MS4A1 Recombinant Antibody, LY2469298, LY 2469298
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.98 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.27 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1850-500 1x 500 µL
PD-L2 / PDCD1LG2 / CD273 (PDL2/1850), 0.2mg/mL
Sign In for Pricing
View Details 